Combination product has been trending in the pharma market, and drug-device combo market is expected to reach $177.7 billion by 2024*.
The regulatory approval pathway for combo product isn’t the easiest, and maintaining market positions in such fierce competition is even more challenging for drug and device developers. A refined and innovative lifecycle management strategy plays a pivotal role to maximizing product longevity and commercial advantage.
Building on the success of PFS & Injectables Summit, the Combination Products Lifecycle Management Summit will create a unique platform for the commercial, quality and regulatory leaders in this segment.
Join this 3-day peer-led summit to stay abreast on market trends and innovations!
Download the full event guide to view the full agenda.
“Although you have been in this industry for decades, you will still learn a lot from this conference!”
Shire, Hanson Wade Event Past Attendee
"I found this conference enjoyable and learned a lot. Several of the speakers shared their own experiences and lessons learned, which I will be able to directly apply in my job"
Pfizer, Hanson Wade Event Past Attendee